Kuerban S, Chen H, Chen L, Zhang L, Li X, Zhen B
World J Surg Oncol. 2025; 23(1):90.
PMID: 40089765
DOI: 10.1186/s12957-025-03747-9.
Shakoori A, Azarian M, Hosseinpour Aghaei M, Maddahi M, Aghazadeh K, Tabari A
Indian J Otolaryngol Head Neck Surg. 2025; 77(1):13-21.
PMID: 40070988
PMC: 11890821.
DOI: 10.1007/s12070-024-05057-0.
Dasi S, Naab T, Kwabi-Addo B, Apprey V, Beyene D, Dewitty Jr R
Cancer Genomics Proteomics. 2025; 22(2):208-230.
PMID: 39993808
PMC: 11880923.
DOI: 10.21873/cgp.20497.
Ishidoya M, Fujita T, Fujii H
Epigenomics. 2025; 17(3):141-143.
PMID: 39929232
PMC: 11812372.
DOI: 10.1080/17501911.2024.2447810.
Bao Y, Wang X, Zeng B, Shi Y, Huang Y, Huang Y
Biomolecules. 2025; 14(12.
PMID: 39766341
PMC: 11727523.
DOI: 10.3390/biom14121634.
Exposure to a Titanium Dioxide Product Alters DNA Methylation in Human Cells.
Wells C, Pogribna M, Sharmah A, Paredes A, Word B, Patri A
Nanomaterials (Basel). 2024; 14(24).
PMID: 39728572
PMC: 11678028.
DOI: 10.3390/nano14242037.
Detection of a novel DNA methylation marker panel for esophageal cancer diagnosis using circulating tumor DNA.
Zheng Y, Xing W, BingWei , Liu X, Liang G, Yuan D
BMC Cancer. 2024; 24(1):1578.
PMID: 39725880
PMC: 11670433.
DOI: 10.1186/s12885-024-13301-7.
Ultrasensitive Amplification-Free Quantification of a Methyl CpG-Rich Cancer Biomarker by Single-Molecule Kinetic Fingerprinting.
Dai L, Johnson-Buck A, Laird P, Tewari M, Walter N
Anal Chem. 2024; 96(43):17209-17216.
PMID: 39425638
PMC: 11648273.
DOI: 10.1021/acs.analchem.4c03002.
Genome-wide methylation profiling reveals extracellular vesicle DNA as an ex vivo surrogate of cancer cell-derived DNA.
Kim K, Kim S, Wortzel I, Lee S, Han Y, Kim T
Sci Rep. 2024; 14(1):24110.
PMID: 39406948
PMC: 11480397.
DOI: 10.1038/s41598-024-75287-3.
The role of DNA methylation and DNA methyltransferases (DNMTs) as potential biomarker and therapeutic target in non-small cell lung cancer (NSCLC).
Mohd Kamal K, Ghazali A, Ab Mutalib N, Abu N, Chua E, Masre S
Heliyon. 2024; 10(19):e38663.
PMID: 39403460
PMC: 11472108.
DOI: 10.1016/j.heliyon.2024.e38663.
Cisplatin resistance-related transcriptome and methylome integration identifies as a novel prognostic biomarker in small cell lung cancer.
Zhu Q, Fu M, Qi J, Xu Z, Wang Y, Wang Z
iScience. 2024; 27(8):110413.
PMID: 39108724
PMC: 11301104.
DOI: 10.1016/j.isci.2024.110413.
Unveiling Bladder Cancer Prognostic Insights by Integrating Patient-Matched Sample and CpG Methylation Analysis.
Kim C, Oh S, Im H, Gim J
Medicina (Kaunas). 2024; 60(7).
PMID: 39064604
PMC: 11279046.
DOI: 10.3390/medicina60071175.
Plasma cell-free DNA methylome-based liquid biopsy for accurate gastric cancer detection.
Qi J, Hong B, Wang S, Wang J, Fang J, Sun R
Cancer Sci. 2024; 115(10):3426-3438.
PMID: 39038922
PMC: 11447983.
DOI: 10.1111/cas.16284.
Ectopic enhancer-enhancer interactions as causal forces driving RNA-directed DNA methylation in gene regulatory regions.
Yang Y, Liu J, Singer S, Yan G, Bennet D, Liu Y
Plant Biotechnol J. 2024; 22(11):3121-3134.
PMID: 39021281
PMC: 11500991.
DOI: 10.1111/pbi.14435.
The common bisulfite-conversion-based techniques to analyze DNA methylation in human cancers.
Jeddi F, Faghfuri E, Mehranfar S, Soozangar N
Cancer Cell Int. 2024; 24(1):240.
PMID: 38982390
PMC: 11234524.
DOI: 10.1186/s12935-024-03405-2.
Hypermethylated TAGMe as a universal-cancer-only methylation marker and its application in diagnosis and recurrence monitoring of urothelial carcinoma.
Yang Z, Chen Q, Dong S, Xu P, Zheng W, Mao Z
J Transl Med. 2024; 22(1):608.
PMID: 38956589
PMC: 11218302.
DOI: 10.1186/s12967-024-05420-3.
Employing emerging technologies such as motion capture to study the complex interplay between genotype and power-related performance traits.
Papadimitriou I
Front Physiol. 2024; 15:1407753.
PMID: 38841210
PMC: 11150552.
DOI: 10.3389/fphys.2024.1407753.
MSA: scalable DNA methylation screening BeadChip for high-throughput trait association studies.
Goldberg D, Cloud C, Lee S, Barnes B, Gruber S, Kim E
bioRxiv. 2024; .
PMID: 38826316
PMC: 11142114.
DOI: 10.1101/2024.05.17.594606.
Hypomethylation of ATP1A1 Is Associated with Poor Prognosis and Cancer Progression in Triple-Negative Breast Cancer.
Kim Y, Ko J, Kong H, Lee M, Chung W, Lim S
Cancers (Basel). 2024; 16(9).
PMID: 38730618
PMC: 11083557.
DOI: 10.3390/cancers16091666.
Blood-Based DNA Methylation Analysis by Multiplexed OBBPA-ddPCR to Verify Indications for Prostate Biopsies in Suspected Prostate Cancer Patients.
Friedemann M, Jandeck C, Tautz L, Gutewort K, von Rein L, Sukocheva O
Cancers (Basel). 2024; 16(7).
PMID: 38611002
PMC: 11010987.
DOI: 10.3390/cancers16071324.